{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:24:36Z","timestamp":1774891476108,"version":"3.50.1"},"reference-count":11,"publisher":"Media Sphere Publishing House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2025,3,6]]},"abstract":"<jats:p>Objective. To analyze the effectiveness of Relatox (Botulinum toxin type A \u2014 hemagglutinin complex) in comparison with Botox in the treatment of primary idiopathic blepharospasm. Material and methods. The study included clinical data for 21 patients with blepharospasm who were treated by botulinum therapy with Botox and Relatox for 3 years. The research method is a one-step retrospective analysis of medical data. Injections were carried out with a 3-month interval. On the 6th cycle, the drug was switched to Relatox. The clinical efficacy of the drugs was assessed using an 8-point Jankovich evaluation scale: the average values before the injection and 14 days after it were compared for each procedure. Results. Mean Jankovich scale scores decreased 2.5-fold for all cycles by the second week after the procedure (4.95 pre-injection vs. 1.8 post-injection), and the mean paired Student\u2019s T-criterion for all injections was 7.14 (with a critical value of 2.021 and a significance level of p=0.05). The mean paired Student\u2019s T-criterion for Botox was \u20136.63 and for Relatox \u20137.5 (with a critical value of 2.021 and a significance level of p=0.05), indicating a high efficacy of both drugs, slightly higher for Relatox. Conclusion. A consistent trend of increasing efficacy with regular botulinum toxin injections and greater efficacy of Relatox compared to Botox in the treatment of patients with primary idiopathic blepharospasm has been demonstrated.<\/jats:p>","DOI":"10.17116\/jnevro202512502186","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:08:52Z","timestamp":1741277332000},"page":"86","source":"Crossref","is-referenced-by-count":3,"title":["Comparative analysis of the effectiveness of Botulinum toxin type A \u2014 hemagglutinin preparations of the Relatox and Botox complex in the treatment of patients with primary idiopathic blepharospasm"],"prefix":"10.17116","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-7074","authenticated-orcid":false,"given":"V.V.","family":"Gusev","sequence":"first","affiliation":[{"name":"Ural State Medical University","place":["Yekaterinburg, Russia"]},{"name":"Ural Federal University named after the first President of Russia B.N. Yeltsin","place":["Yekaterinburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8477-2742","authenticated-orcid":false,"given":"E.A.","family":"Makarov","sequence":"additional","affiliation":[{"name":"Ural State Medical University","place":["Yekaterinburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-3096","authenticated-orcid":false,"given":"O.A.","family":"Lvova","sequence":"additional","affiliation":[{"name":"Ural State Medical University","place":["Yekaterinburg, Russia"]},{"name":"Ural Federal University named after the first President of Russia B.N. Yeltsin","place":["Yekaterinburg, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202512502186-1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26934"},{"key":"key-10.17116\/jnevro202512502186-2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12040269"},{"key":"key-10.17116\/jnevro202512502186-3","unstructured":"Dystonia. Clinical guidelines. 2024. (In Russ.)"},{"key":"key-10.17116\/jnevro202512502186-4","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-021-02366-4"},{"key":"key-10.17116\/jnevro202512502186-5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22368"},{"key":"key-10.17116\/jnevro202512502186-6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120319"},{"key":"key-10.17116\/jnevro202512502186-7","doi-asserted-by":"publisher","DOI":"10.3410\/f.726345042.793519461"},{"key":"key-10.17116\/jnevro202512502186-8","unstructured":"Artemenko AR, Kurenkov AL, Belomestova KV. On the absence of interchangeability of botulinum toxin type A drugs. Medical Sovet. 2015;5:112-123. (In Russ.)"},{"key":"key-10.17116\/jnevro202512502186-9","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0323-3"},{"key":"key-10.17116\/jnevro202512502186-10","unstructured":"https:\/\/grls.rosminzdrav.ru\/Grls_View_v2.aspx?routingGuid=3e682ada-5ea7-4782-aacd-a07f2787d820 PIL (patient information leaflet) LP-002949 BOTOX\u00ae Botulinum toxin type A hemagglutinin complex. State medicine register. (In Russ.). Available et: @@https:\/\/grls.rosminzdrav.ru\/Grls_View_v2.aspx?routingGuid=3e682ada-5ea7-4782-aacd-a07f2787d820"},{"key":"key-10.17116\/jnevro202512502186-11","unstructured":"https:\/\/grls.rosminzdrav.ru\/Grls_View_v2.aspx?routingGuid=857bb5b2-f69e-4462-9b2d-b92ad0f2659e PIL (patient information leaflet) LP-\u2116 (006910)-(RG-RU) RELATOX\u00ae Botulinum toxin type A in combination with hemagglutinin. State medicine register. (In Russ.). Available et: @@https:\/\/grls.rosminzdrav.ru\/Grls_View_v2.aspx?routingGuid=857bb5b2-f69e-4462-9b2d-b92ad0f2659e"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:09:40Z","timestamp":1741277380000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2025\/2\/1199772982025021086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,6]]}},"alternative-id":["10.17116\/jnevro202512502186"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202512502186","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}